(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker AstraZeneca from £140 to £142 per share on Wednesday, citing "strong pipeline readouts" which were yet to be reflected in its share price.
Berenberg increased its 2030 revenue forecast for AstraZeneca by roughly 3% to $79.0bn, ahead of consensus...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE